The prevention of multiple long term conditions needs to be higher up the healthcare agenda and for this to happen we need to be more precise about what we mean when talking about it. As populations ...

Many people requiring secondary prevention drugs for CVD do not receive them. This trend persisted even in countries considered high income. Underuse was even more pronounced in lower-income ...

Prophylactic aspirin in healthy, elderly patients provides no benefit and causes harm; clinicians should not use it for primary prevention in otherwise well patients aged over 70. As the world’s ...

Anderson, M.D., from the University of Pittsburgh, characterized national trends in preventive aspirin use (primary and secondary prevention) among populations at low and high ASCVD risk and with ...